> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Vanguard Portfolio Management Reports 5.04% Passive Stake In IDEXX
- URL: https://www.bullished.co/vanguard-portfolio-management-reports-5-04-passive-stake-in-idexx-766ffdd2/
- Published: 2026-10-30T18:16:02.000Z
- Updated: 2026-11-05T18:52:18.000Z
- Description: The Vanguard unit's 3,974,472 shares are held as an investment adviser, with no aim to influence control of the veterinary diagnostics company.
- Author: Matteo Parrino
- Tags: SEC Filings, IDXX, Industry: Healthcare

Vanguard Portfolio Management holds a [5.04% stake](https://www.sec.gov/Archives/edgar/data/0002100121/000210012126001090/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) in [IDEXX Laboratories](https://www.bullished.co/tag/idxx/), which makes diagnostic products for veterinary clinics, livestock producers and water testing, according to a passive ownership disclosure filed Friday. The position totals 3,974,472 shares.

## A 5.04% position, mostly without votes

The filing lists September 30, 2026 as the triggering event and classifies Vanguard Portfolio Management as an investment adviser. Its sole voting power covers [18,545 shares](https://www.sec.gov/Archives/edgar/data/0002100121/000210012126001090/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co), and it reports no shared voting power.

The percentage is computed on a Rule 13d-3 basis, which counts shares the holder could acquire within 60 days.

The reported holdings also include shares held by two affiliates, Vanguard Fiduciary Trust Company and Vanguard Global Advisers. The position covers Vanguard funds, or parts of them, over which the unit has dispositive power, meaning the power to decide on sales.

## No intent to influence control

Vanguard certified that the shares were acquired and are held in the ordinary course of business. It said they are not held to change or influence control of IDEXX.

That certification is why the filing is a passive one rather than an activist disclosure.

## IDEXX's business and its stock

IDEXX, based in Westbrook, Maine, sells in-clinic analyzers, rapid tests, reference laboratory testing and software to veterinarians. It also runs water-testing and livestock, poultry and dairy segments.

IDEXX shares traded at $555.91 in Friday trading, down 3.48% from the prior close of $575.98, and the company's market value was $45.4 billion. The stock was down 16.79% year to date as of an [Oct. 28 commentary](https://finance.yahoo.com/healthcare/articles/zoetis-zts-vs-idxx-elan-171746402.html?ref=bullished.co) by Ricardo Pillai on Yahoo Finance, which set that against a 38.17% decline for animal-health rival Zoetis.

IDEXX's third-quarter report is the next company event. Analyst consensus ahead of it called for [revenue of $1.19 billion](https://finance.yahoo.com/markets/stocks/articles/gear-idexx-idxx-q3-earnings-121503580.html?.tsrc=rss&ref=bullished.co), up 7.5% from a year earlier, and earnings of $3.71 per share.

Learn

- [What a Reverse Termination Fee Means: Who Pays When a Merger Collapses →](https://www.bullished.co/learn/reverse-termination-fee-meaning/)  
A reverse termination fee is paid by the buyer to the target if a merger fails on agreed terms. See how it differs from a break-up fee, with live deal examples.
- [How To Read A Merger Proxy: A Checklist For Shareholders Facing A Vote →](https://www.bullished.co/learn/merger-proxy-statement-how-to-read/)  
Facing a merger vote? Read the proxy in this order: price and payment, vote date and threshold, board background, synergy claims, then closing conditions.

### Sources

- [SCHEDULE 13G — Vanguard Portfolio Management re: IDEXX Laboratories Inc (IDXX)](https://www.sec.gov/Archives/edgar/data/0002100121/000210012126001090/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR
- [Gear Up for Idexx (IDXX) Q3 Earnings: Wall Street Estimates for Key Metrics](https://finance.yahoo.com/markets/stocks/articles/gear-idexx-idxx-q3-earnings-121503580.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [Zoetis (ZTS) vs. IDXX and ELAN: Is Valuation Compression Creating a Rare Opportunity in Animal Health?](https://finance.yahoo.com/healthcare/articles/zoetis-zts-vs-idxx-elan-171746402.html?ref=bullished.co) — Yahoo Finance

### More on IDEXX Laboratories

- [IDEXX CEO Jonathan Mazelsky Plans To Sell 25,140 Shares Worth $17.7 Million](https://www.bullished.co/idexx-ceo-jonathan-mazelsky-plans-to-sell-25-140-shares-worth-17-7-million-4c7fa41b/)
- [IDEXX CEO Calls $15 Cancer Screen 'One Of The Most Consequential Innovations' In Company History](https://www.bullished.co/idexx-ceo-calls-15-cancer-screen-one-of-the-most-consequential-innovations-in-company-6322bd54/)
- [IDEXX Stock Soars 17%, Adding $7.5 Billion, After Raising 2026 Revenue And Earnings Outlook](https://www.bullished.co/idexx-stock-soars-17-adding-7-5-billion-after-raising-2026-revenue-and-earnings-outlook-1fc34fd9/)

[All IDEXX Laboratories (IDXX) coverage →](https://www.bullished.co/tag/idxx/)